Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
Hytrin 2 mg Tablets.
Terazosin 2 mg Tablets.
Yellow, round, flat bevelled tablets embossed with logo and triangular facets on one face and plain on the other.
Each tablet contains 2 mg of terazosin as monohydrochloride dihydrate.
Excipients with known effect:
Lactose (127.28 mg)
Quinoline yellow aluminium lake E104 (0.100 mg)
For a full list of excipients, see section 6.1.
Dye yellow (quinolone yellow, E104)
Tablets in a blister pack. The 2mg tablets are supplied in a pack of 28 tablets. Blisters are packaged in a carton with a package insert.
Starter Pack for Hypertension: The 2mg tablets form part of a starter pack of 28 tablets which also contains 7 × 1mg tablets. Blisters are packaged in a carton with a package insert.
Starter pack for BPH: Tablets in a blister pack. The starter pack consists of 7 × 1mg, 14 × 2mg and 7 × 5mg tablets. The blisters, of PVC/PVdC, are heat sealed with 20 micron hard tempered aluminium foil and packaged in a carton with a pack insert.
Amdipharm UK Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.